Oranex Capsule

ANTI FIBRINOLYTIC: Tranexamic acid

Indication

1. Fibrinolysis may occur in conditions:
– Prostatectomy and bladder surgery
– Menorrhagia
– Epistaxis
– Haematuria
– Conisation of the cervix
– Management of dental extraction in patients with coagulopathies
2. Hereditary angioneurotic oedema

Contraindication

Tranexamic Acid is contraindicated in patients with-
Active thromboembolic diseaseSubarachnoid haemorrhage
Hypersensitivity to any of the ingredients

Dosage & Administration

Prostatectomy: 2-3 capsules orally 3 to 4 times daily until macroscopic haematuria is no longer present
Menorrhagia: 2-3 capsules orally 3 to 4 times daily for three to four days
Epistaxis: 3 capsules orally 3 times daily for four to ten days
Haematuria: 2-3 capsules orally 2 to 3 times daily until macroscopic haematuria is no longer present
Conisation of the Cervix: 3 capsules orally 3 times a day for twelve to fourteen days
post-operatively Dental surgery in patients with coagulopathies: Before surgery, 10 mg/kg body weight and after surgery, 25 mg/kg body weight are given orally 3 to 4 times daily for six to eight days
Hereditary angioneurotic oedema: 2-3 capsules orally two to three times daily
Patients with renal insufficiency: Use more cautiously
Children dosage: 25 mg/Kg, 2 to 3 times daily for seven to ten days. Children should be above 15 years

Side Effect

Nausea, vomiting, dizziness, headache and rarely allergic skin reactions.

Drug Interaction

Clinically important interactions have not been observed with Tranexamic Acid.

Presentation

Oranex  Capsule: Box containing 2 x 10\’s capsules in Alu-PVDC pack.